Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000.

MLA

Kantarjian, Hagop M., et al. “Results of Second Salvage Therapy in 673 Adults with Acute Myelogenous Leukemia Treated at a Single Institution since 2000.” Cancer (0008543X), vol. 124, no. 12, June 2018, pp. 2534–40. EBSCOhost, https://doi.org/10.1002/cncr.31370.

APA

Kantarjian, H. M., DiNardo, C. D., Nogueras, G. G. M., Kadia, T. M., Jabbour, E., Bueso, R. C. E., O’Brien, S. M., Konopleva, M., Jain, N. B., Daver, N. G., Shpall, E. J., Champlin, R. E., Simkins, A., Garcia, M. G., Keating, M. J., Huang, X., Cortes, J. E., Pierce, S. A., Ravandi, F., & Freireich, E. J. (2018). Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000. Cancer (0008543X), 124(12), 2534–2540. https://doi.org/10.1002/cncr.31370

Chicago

Kantarjian, Hagop M., Courtney D. DiNardo, Gonzalez, Graciela M. Nogueras, Tapan M. Kadia, Elias Jabbour, Ramos, Carlos E. Bueso, Susan M. O’Brien, et al. 2018. “Results of Second Salvage Therapy in 673 Adults with Acute Myelogenous Leukemia Treated at a Single Institution since 2000.” Cancer (0008543X) 124 (12): 2534–40. doi:10.1002/cncr.31370.